Craig A. Tooman, Executive VP Finance, CFO at ENZON PHARMACEUTICALS INC (ENZN), bought 1,000 shares at $8.19 ($8K) on 2007-05-11, disclosed to the SEC on 2007-05-14.
Open-market purchase of $8k ENZN by Executive VP Finance, CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| PETX | SELL | 2016-02-02 | $9K | — | Filing → |
| PETX | SELL | 2015-11-10 | $27K | — | Filing → |
| PETX | SELL | 2015-10-02 | $26K | — | Filing → |